Adenosine Receptors in Neurodegenerative Diseases 2017
DOI: 10.1016/b978-0-12-803724-9.00001-6
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine Receptor Biology in the Central Nervous System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 113 publications
0
1
0
Order By: Relevance
“…Namely, A 1 Rs are able to form oligomers with dopamine D 1 and mGlu1 (metabotropic glutamate type 1) receptors, whereas A 2A R can form oligomers with dopamine D 2 , mGlu5 (metabotropic glutamate type 5), or CB 1 cannabinoid receptors. [10][11][12][13] Furthermore, the relevance of adenosine signaling in the CNS under several pathological conditions, such as Parkinson's disease (PD), Huntington's disease (HD), or multiple sclerosis (MS) has already been described (reviewed in Fredholm et al 14 ).…”
Section: Introductionmentioning
confidence: 99%
“…Namely, A 1 Rs are able to form oligomers with dopamine D 1 and mGlu1 (metabotropic glutamate type 1) receptors, whereas A 2A R can form oligomers with dopamine D 2 , mGlu5 (metabotropic glutamate type 5), or CB 1 cannabinoid receptors. [10][11][12][13] Furthermore, the relevance of adenosine signaling in the CNS under several pathological conditions, such as Parkinson's disease (PD), Huntington's disease (HD), or multiple sclerosis (MS) has already been described (reviewed in Fredholm et al 14 ).…”
Section: Introductionmentioning
confidence: 99%